InvestSMART

Holista Colltech Limited (ASX: HCT) - Share Price

- Current share price for HCT : $0.080

Holista Colltech Ltd (HCT), an ASX-listed company, is a Company that is engaged in manufacture and sale of health-style products, focusing on Dietary Supplements, Healthy Food Ingredients, Ovine Collagen and Infection Control / Agriculture.

HCT General Information +

ASX Code HCT
Website http://www.holistaco.com
Industry/Sector Personal Products
Market Cap ($M) 29
HCT Share Price $0.080
Day High $0.085
Day Low $0.080
Last Close $0.080
HCT Share Price Movement - ( No change )
Prices as at 16:36, 22 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Holista Colltech Limited (HCT) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Holista Colltech Limited (HCT) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Holista Colltech Limited (HCT) price-sensitive announcements

HCT - Holista Executes Binding JV for Collie Collagen Facility
Holista Colltech Limited announced a binding joint venture agreement with Swang Chai Chuan
Holista Colltech Limited (HCT)
5 May 2026 | 8:16 AM
HCT - Quarterly Activity and Cashflow Report
Holista Colltech Limited, an Australian company, reported its quarterly activities and cas
Holista Colltech Limited (HCT)
28 Apr 2026 | 4:55 PM
HCT - Reinstatement to Quotation
The Australian Securities Exchange (ASX) announced the reinstatement to quotation of Holis
Holista Colltech Limited (HCT)
22 Apr 2026 | 2:55 PM
HCT - ProImmune Judgement and Settlement
Holista Colltech Limited announced that the Supreme Court of Western Australia ruled in fa
Holista Colltech Limited (HCT)
22 Apr 2026 | 2:55 PM

Holista Colltech Limited (HCT) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Holista Colltech Limited (HCT)
ORDINARY FULLY PAID
 Consumer Staple $29 Final Payment Made in Settlement of ProImmune Litigation 17 Jul 2026 8:38AM $0.080 $0.080 fallen by 0%
Holista Colltech Limited (HCT)
ORDINARY FULLY PAID
 Consumer Staple $29 Proposed issue of securities - HCT 9 Jul 2026 11:04AM $0.080 $0.080 fallen by 0%
Holista Colltech Limited (HCT)
ORDINARY FULLY PAID
 Consumer Staple $29 Convertible Loan to Fund Settlement of ProImmune Matter 9 Jul 2026 10:26AM $0.080 $0.080 fallen by 0%
Holista Colltech Limited (HCT)
ORDINARY FULLY PAID
 Consumer Staple $29 Acquisition of Industrial Land in Collie 19 Jun 2026 8:21AM $0.067 $0.080 risen by 19.40%
Holista Colltech Limited (HCT)
ORDINARY FULLY PAID
 Consumer Staple $29 Clarification - Binding JV for Collie Collagen Facility 17 Jun 2026 4:28PM $0.071 $0.080 risen by 12.68%
Holista Colltech Limited (HCT)
ORDINARY FULLY PAID
 Consumer Staple $29 Results of Meeting 25 May 2026 5:19PM $0.070 $0.080 risen by 14.29%

HCT Financial Summary

Year to Dec NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A $0.14 N2 -157.10% 159.00 0.00 0.00% 0.0%
2024A -$0.20 -$0.10 -46.20% 0.00 0.00 0.00% 0.0%
2023A -$2.38 -$0.10 -75.50% 0.00 0.00 0.00% 0.0%

HCT Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Holista Colltech Limited (HCT) $29M -1.5714 0.0000 0.0000 200.0000 0.0000 0.0000 0.00% 0.00% 0.00%

HCT Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 1.11 200.00 26.70 0.00
Market 0.31 12.80 1.12 0.58
Sector 0.00 200.00 0.89 0.00

HCT Directors

Name Position Start Date
Mr Leong Man Loong Non-Executive Director 3 Jan 2025
Mr Gregory(Greg) Pilant Non-Executive Director 26 Mar 2025
Mr Sam Yee Yuen Keong Yee Non-Executive Director 14 May 2025
Mr Robert Gemelli Non-Executive Director 14 May 2025
Mr Lai Kwok Kin Non-Executive Director, Non-Executive Chairman 19 Mar 2024

Holista Colltech Limited (HCT) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
31 Jan 2019 RAJENDRAN, Marnickavasagar (Manicka) Buy Direct Shares 4,355 $0.055 $239.525
31 Jan 2019 RAJENDRAN, Marnickavasagar (Manicka) Buy Direct Shares 42,793 $0.057 $2,439.201
31 Jan 2019 MARNICKAVASAGAR (MANICKA), Rajendran Buy Direct Shares 4,355 $0.055 $239.525

See all changes in directors' interest & trades for Holista Colltech Limited (HCT) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

HCT Management

Name Position
Jay Richard Stephenson Company Secretary

HCT Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Holista Colltech Limited (HCT). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
85,735,272 (23.31%) Rajen Manicka
36,159,845 (9.83%) Leong Man Loong
30,234,317 (8.22%) Gregory Pilant

HCT Calendar of Events

Date Event
29 March 2027 Report (Annual)
26 February 2027 Report (Prelim)
28 August 2026 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.